Loading...
NuCana plc
NCNA•NASDAQ
Healthcare
Biotechnology
$0.06
$-0.02(-26.88%)
NuCana plc (NCNA) Financial Performance & Statements
Review NuCana plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
27.69%
↑ 27.69%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-320.25%
↓ 320.25%
ROIC
-403.50%
↓ 403.50%
NuCana plc (NCNA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for NuCana plc stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $729000.00 | $3.74M | $6.77M | $6.78M |
| SG&A Expenses | $540000.00 | $1.36M | $1.51M | $1.58M |
| Operating Expenses | $865000.00 | $5.32M | $8.35M | $8.36M |
| Total Costs & Expenses | $865000.00 | $5.32M | $8.35M | $8.36M |
| Interest Income | $75000.00 | $72000.00 | $85000.00 | $126000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $115000.00 | $135000.00 | $136000.00 | $136000.00 |
| EBITDA | -$1.15M | -$4.96M | -$8.14M | -$8.23M |
| EBITDA Ratio | ||||
| Operating Income | -$865000.00 | -$5.32M | -$8.35M | -$8.27M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $75000.00 | $72000.00 | $85000.00 | $126000.00 |
| Income Before Tax | -$790000.00 | -$5.25M | -$8.27M | -$8.14M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | -$137000.00 | -$740000.00 | -$1.27M | -$1.30M |
| Net Income | -$653000.00 | -$4.51M | -$7.00M | -$6.84M |
| Net Income Ratio | ||||
| EPS | -$7.25 | -$49.75 | -$77.25 | -$79.75 |
| Diluted EPS | -$7.25 | -$49.75 | -$77.25 | -$79.75 |
| Weighted Avg Shares Outstanding | $90656.00 | $90656.00 | $90656.00 | $85723.00 |
| Weighted Avg Shares Outstanding (Diluted) | $90656.00 | $90656.00 | $90656.00 | $85723.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan